Maxioms by Frank Aquila
Neither company has a strong interest in seeing this resolved in the court.
Neither company has a strong interest in seeing this resolved in the court.
When we look back in three years, there's going to be a higher likelihood that those companies that repatriated substantial read more
When we look back in three years, there's going to be a higher likelihood that those companies that repatriated substantial non-U.S. profits have done major transactions compared with companies that have not repatriated assets.
It's very clear Boston Scientific is not making this acquisition for what this company can do in 2006, 2007. This read more
It's very clear Boston Scientific is not making this acquisition for what this company can do in 2006, 2007. This is a long-term strategic acquisition for them.
There is really a trend of consolidation across many, many industries and geographies. The pipeline is full, and I think read more
There is really a trend of consolidation across many, many industries and geographies. The pipeline is full, and I think we'll see a lot of transactions in the next few months.
When all is said and done, what you'll probably see is some sort of negotiated settlement here, whether it's a read more
When all is said and done, what you'll probably see is some sort of negotiated settlement here, whether it's a breakup fee, or lower purchase price, ... Neither company has a strong interest in seeing this resolved in the court.